Suven Pharmaceuticals Ltd. is a pharmaceutical company based in India with a low risk ESG score of 13.2. Specializing in the development and manufacturing of Intermediates, Active Pharmaceutical Ingredients (API), and specialty chemicals, the company also offers formulated drugs under Contract Research and Manufacturing Services (CRAMS) for global pharmaceutical, biotechnology, and chemical companies. With a focus on Pharmaceuticals Manufacturing & Services, Suven Pharmaceuticals operates in geographical segments including India, the USA, Europe, and the Rest of the World, with a majority of its revenue coming from the Europe segment.